Competing in the Global Contract Manufacturing Market

Competing in the Global Contract Manufacturing Market

What Pharmaceutical and Biotechnology Companies Want and How to Compete for their Business

RELEASE DATE
28-Oct-2013
REGION
Global
Research Code: ND00-01-00-00-00
SKU: LS00042-GL-CR_16883
$10,000.00
In stock
SKU
LS00042-GL-CR_16883
$10,000.00
DownloadLink

Pay by invoice

ENQUIRE NOW

Description

The overall objective of this study was to provide contract manufacturing organizations (CMOs) a sound basis for formulating an effective strategy to compete in the market, including areas of opportunities and threats. As far as the market dynamics and CMO selection are concerned, overall satisfaction and likelihood of contract renewal are in the 40–50% range across all product types, indicating opportunity for CMO vendor switching in the future. Of all parameters used in CMO agreements and selection, “volume commitments” ranks as the most important while “capacity and site transfer” ranks second. Overall, pharmaceutical and biotechnology companies prefer to outsource to CMO companies which possess operations in the same region.

Table of Contents

Introduction

  • Title, Research Team, and Table of Contents

Research Objectives

  • Research Objectives and Methodology

Executive Summary

  • Executive Summary

An Overview of the Global Contract Manufacturing Market

  • Overview

Impact of Attitudes and Perceptions on CMO Outsourcing

  • Segmentation of Global Pharmaceutical and Biotechnology Companies

Preferred CMOs and Drivers of their Selection

  • Overview

The Outsourcing and Manufacturing Markets

  • Assessing Growth Opportunities and Threats

Areas of Marketing Opportunities

  • Overview

Appendices

  • Additional Details

The Frost & Sullivan Story

  • Overview
Related Research
The overall objective of this study was to provide contract manufacturing organizations (CMOs) a sound basis for formulating an effective strategy to compete in the market, including areas of opportunities and threats. As far as the market dynamics and CMO selection are concerned, overall satisfaction and likelihood of contract renewal are in the 4050% range across all product types, indicating opportunity for CMO vendor switching in the future. Of all parameters used in CMO agreements and selection, volume commitments ranks as the most important while capacity and site transfer ranks second. Overall, pharmaceutical and biotechnology companies prefer to outsource to CMO companies which possess operations in the same region.
More Information
No Index No
Podcast No
Author Karolina Olszewska
WIP Number ND00-01-00-00-00
Is Prebook No